Renpeng Gu

Renpeng Gu has a diverse and extensive work experience. Renpeng began their career in 2008 as a Research Assistant at Zhejiang University, where they improved oil-solubility of graphite oxide and applied Langmuir-Blodgett technique to obtain graphite oxide membrane on silicon wafer. In 2009, they served as a Research Assistant at North Carolina State University, where they prepared carbon black doping LiFePO4 cathode of Lithium-ion Battery. Renpeng also spent 2009 as a Research Assistant at Zhejiang University, synthesizing PS-block-P(MAn-co-VAc) and PAA-block-P(MAn-co-VAc) using RAFT polymerization and self-assembling the block polymers to micelle or other micro-nanostructure. From 2010 to 2012, Renpeng Gu was a Doctoral Research Assistant and Postdoctoral Associate at Duke University, where they developed strategies and scientific approaches to attach azide and alkyne groups to polysaccharides and proteins and quantified the incorporated azide and alkyne groups using MALDI and fluorescent probe. Renpeng also advanced Pfizer's next-generation vaccine by developing protein - polysaccharide conjugates using click chemistry. In 2019, Renpeng Gu began a Postdoctoral Research Fellow position at Boston College, where they developed a novel strategy to edit the genome at predefined location for directed evolution. Finally, in 2021, they became a Scientist I, Molecular & Cell Biology at SalioGen Therapeutics.

Renpeng Gu attended Zhejiang University from 2006 to 2010, where they obtained a Bachelor of Engineering (BEng) degree in Polymer Materials and Engineering. Renpeng then attended Western University from 2010 to 2012, where they obtained a Master of Science (MS) degree in Chemical and Biomolecular Engineering. Finally, they attended Duke University from 2012 to 2018, where they obtained a Doctor of Philosophy (PhD) degree in Materials Science.